As pancreatic cancer patients are at an increased risk of venous thrombosis, another possible research interest would be to investigate the association between platelets and thromboembolism-associated factors in patient prognosis as an earlier study on a pan-cancer cohort demonstrated increased levels of cancer-associated tumor thromboembolism (VTE)-associated factors such as ADAMTS-13 and VWF in patients having worse survival rates (Obermeier et al., 2019). This evidence concerns the gene VWF and cancer.